We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
A picture of Laura Elizabeth Lansdowne

Laura Elizabeth Lansdowne profile page

Managing Editor

 at Technology Networks


As managing editor, Laura works with the editorial director to create, inform and maintain the overall editorial strategy for Technology Networks. She oversees the in-house editorial team and works directly with commissioned writers to produce content across the publication’s communities. After obtaining a first-class honors degree in biology, Laura worked as a quality assurance technologist before joining the Wellcome Sanger Institute and undertaking an additional qualification in clinical chemistry. In 2015, she left to pursue pharmaceutical and editorial-based roles, before joining Technology Networks in 2017.


Education


University of Kent  

Nottingham Trent University  

Writtle University College  

Chartered Institute of Editing and Proofreading  


Accreditations


Biology, BSc (Hons) recognised by The University of Kent


Areas of Expertise



Got a Question for Laura Elizabeth Lansdowne?


Get in touch using the contact form linked here and we’ll get back to you shortly.



Published Content
Total: 410
Leveraging the T-Cell Response to Epstein-Barr Virus To Treat Life-Threatening Diseases content piece image
Industry Insight

Leveraging the T-Cell Response to Epstein-Barr Virus To Treat Life-Threatening Diseases

Technology Networks recently spoke with Jakob Dupont, head of global research & development at Atara Bio, to learn more about the company’s novel allogeneic EBV T-cell platform and discover how it’s enabling a differentiated approach to allogeneic cell therapy.
Opinionated Science Episode 40: A Herpes-MS Link, mRNA Pills and Regenerating Frog Limbs content piece image
Podcast

Opinionated Science Episode 40: A Herpes-MS Link, mRNA Pills and Regenerating Frog Limbs

In the latest Opinionated Science, the first of 2022, the TN team discusses why multiple sclerosis links to a herpesvirus, a limb regenerating Fitbit that has amputee frogs hopping again and the next era of pill-based mRNA technology.

Harnessing the Immune System To Treat Cancer content piece image
Article

Harnessing the Immune System To Treat Cancer

In this article, we consider some of the work being done to enhance the T-cell response to tumors, discuss the promise of oncolytic virotherapy and highlight the potential benefits of combined therapy.
Women in Science: Perspectives From Industry content piece image
Industry Insight

Women in Science: Perspectives From Industry

In honor of International Day of Women and Girls in Science 2022, Technology Networks interviewed three women who have built successful careers within the scientific industry, to learn about their career paths and the reasons they chose to work in industry.
Understanding Polyps and Their Colorectal Cancer Counterparts  content piece image
News

Understanding Polyps and Their Colorectal Cancer Counterparts

Researchers from Vanderbilt University have discovered how polyps develop into colorectal cancer. This knowledge could help to improve how this type of cancer is monitored and treated. The study was published in Cell.
Alleviating the Burden of NGS Library Preparation content piece image
Industry Insight

Alleviating the Burden of NGS Library Preparation

Next-generation sequencing (NGS) has undoubtedly revolutionized the genomics field and thanks to technological advances in recent years, laboratories around the globe are now applying NGS to a wide variety of applications. However, library sample preparation remains a key bottleneck and researchers are now looking to adopt automation solutions to alleviate this pain point. Technology Networks recently spoke with Paul Lomax, product manager at SPT Labtech to learn more about firefly®, the company’s new liquid handling platform for NGS library preparation.
Novel Psychoactive Substances content piece image
Infographic

Novel Psychoactive Substances

Novel psychoactive substances (NPS) are compounds that are designed to mimic the effects of established illicit drugs. Many NPS emerged during the early- to mid-2000s and the number of new substances being reported continues to rise. Download this infographic to explore various NPS and key characteristics, reveal why they challenge traditional approaches to drug monitoring and discover methods used to detect NPS.
The Pursuit of Global, Sustainable and Cooperative Open Science content piece image
Article

The Pursuit of Global, Sustainable and Cooperative Open Science

Technology Networks had the pleasure of speaking with Nobel Laureate Elizabeth Blackburn on her impressive contributions to science and society. She highlights early inspirations that cemented her love of science, elaborates on the research that led to her being co-awarded the 2009 Nobel Prize in Physiology or Medicine, and explains why she is advocating for sustainable, cooperative and open science.
Drug Cocktail Enables Frogs To Regenerate Amputated Limbs content piece image
News

Drug Cocktail Enables Frogs To Regenerate Amputated Limbs

Researchers have developed a multidrug-loaded wearable bioreactor that can trigger the restoration of amputated hindlimbs in adult African clawed frogs (Xenopus laevis). The animals were able to regrow and remodel a missing limb and sensorimotor function was restored.
Milestones in Cancer Drug Discovery content piece image
Infographic

Milestones in Cancer Drug Discovery

Download this infographic to explore major cancer drug discovery milestones throughout history and the five pillars of modern-day cancer treatment.
Advertisement